
Biofrontera Inc.
BFRINasdaqCIK 1858685HealthcareFiscal year ends Dec 31
Reports and events: 166 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-11-2209:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-047306 |
| 2024-11-1418:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045220 |
| 2024-11-1317:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045205 |
| 2024-10-3115:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-043187 |
| 2024-10-0708:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-039652 |
| 2024-08-1416:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-032328 |
| 2024-08-1416:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-032216 |
| 2024-06-2408:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-024881 |
| 2024-06-1416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-023888 |
| 2024-05-2216:30 ET | 8-K | 8.01 Other events | 0001493152-24-021019 |
| 2024-05-1517:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-020031 |
| 2024-05-1516:16 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019878 |
| 2024-05-0309:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-017641 |
| 2024-05-0321:32 ET | S-1 | Registration statement | 0001493152-24-017613 |
| 2024-04-3016:40 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-017255 |
| 2024-04-2516:45 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-015949 |
| 2024-04-1717:21 ET | DEF 14A | Proxy statementPeriod 2024-04-17 | 0001493152-24-015042 |
| 2024-04-0317:00 ET | 8-K/A | 8.01 Other events | 0001493152-24-013031 |
| 2024-03-2616:45 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-011323 |
| 2024-03-2120:41 ET | DEF 14A | Proxy statementPeriod 2024-03-20 | 0001493152-24-010706 |
| 2024-03-2020:44 ET | S-1/A | Registration statement, amended | 0001493152-24-010552 |
| 2024-03-1517:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-010152 |
| 2024-03-1517:00 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-010133 |
| 2024-03-1118:45 ET | S-1 | Registration statement | 0001493152-24-009456 |
| 2024-02-2309:26 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-007616 |
| 2024-02-2009:37 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-007143 |
| 2024-02-1321:39 ET | 8-K | 8.01 Other events | 0001493152-24-005946 |
| 2024-02-0517:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-004964 |
| 2024-02-0216:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-004771 |
| 2024-01-2909:23 ET | S-1/A | Registration statement, amended | 0001493152-24-004089 |
| 2024-01-2516:30 ET | 8-K | 3.01 Delisting notice | 0001493152-24-003756 |
| 2024-01-1719:23 ET | S-1 | Registration statement | 0001493152-24-002533 |
| 2024-01-1116:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-002083 |
| 2024-01-0917:01 ET | 8-K/A | 1.02 Termination of a material agreement | 0001493152-24-001848 |
| 2024-01-0317:27 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-000334 |
| 2023-12-2817:25 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001493152-23-046414 |
| 2023-12-2717:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-046279 |
| 2023-12-1517:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-045074 |
| 2023-11-2916:30 ET | 8-K | 3.01 Delisting notice | 0001493152-23-043068 |
| 2023-11-1706:02 ET | DEF 14A | Proxy statementPeriod 2023-11-17 | 0001493152-23-041752 |
| 2023-11-0917:23 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040132 |
| 2023-11-0917:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-040113 |
| 2023-11-0217:10 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-039171 |
| 2023-10-2721:00 ET | S-1/A | Registration statement, amended | 0001493152-23-038442 |
| 2023-10-1621:59 ET | S-1/A | Registration statement, amended | 0001493152-23-037266 |
| 2023-10-1317:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-037236 |
| 2023-10-1009:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-036673 |
| 2023-10-0521:48 ET | S-1 | Registration statement | 0001493152-23-035722 |
| 2023-10-0408:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-035321 |
| 2023-10-0317:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-035275 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 22:16 ET. Listed shows no prices and gives no investment advice.